美国Gene Bridges公司中国代理：上海华雅思创生物科技有限公司

Company

Gene Bridges GmbH, founded 2000 as a spin-off of the European Molecular Biology Laboratories (EMBL), commercialises the patented Red/ETRecombination technology. In May 2004, Gene Bridges opened its Commercial Centre (Licensing, DNA Engineering Services, Kit development) in the Technology Park in Heidelberg.

Directors

A. Francis Stewart, Chairman, is Professor of genomics in a new research center, BIOTEC, at the Technische Universitaet Dresden. From 1991-2001 he was a Group Leader at the European Molecular Biology Laboratory (EMBL) Heidelberg, where his group specialized in advanced genetic engineering strategies using site specific and homologous recombination. Notable accomplishments were pioneering the ligand-inducible strategy of site specific recombination that is now prominent in mouse genetics; and, with Youming Zhang and Frank Buchholz, discovering Red/ET Recombination. He received his PhD from the University of N.S.W., Sydney, Australia and did post-doctoral work with Guenther Schuetz at the Deutsche Krebsforschungzentrum, Heidelberg.

Gary Stevens, Chief Executive Officer, combines more than twenty years experience in the Pharmaceutical Industry with a background in Marketing and Business Development. Prior to co-founding Gene Bridges, he worked with Hoechst and other international organisations in various European countries.

Youming Zhang, Chief Scientific Officer, is responsible for the coordination of research and development. He worked for over 5 years as a postdoctoral researcher at the University of Heidelberg and at the European Molecular Biology Laboratory (EMBL) in Heidelberg. Youming Zhang and his colleagues discovered and developed Red/ET Recombination technologies in Francis Stewart's laboratory in EMBL, he holds a PhD degree from the University of Heidelberg, MSc degree in Molecular Biology and Biochemistry from Peking Union Medical College in China and a BSc degree in Biochemistry from the Xiamen University in China.

美国Gene Bridges品牌的产品在中国市场上主要是以代 理商销售，上海华雅思创生物公司的核心就是在中国代理各种生物类产品（涉及生物医药、疫苗研发生产、生命科学研究、疾病诊断、生物工程等等）的营销 和服务工作。

在中国地区，Gene Bridges中国代理：上海华雅思创生物公司起着重要的传递科学价值，服务科学研究。

上海华雅思创生物科技有限公司在中国代理 的生物类产品已经成功销往上海市、北京市、重庆市、天津市、浙江省的杭州市、宁波、温州、江苏省的南京市、苏州、无锡、泰州、广东省的广州市、深圳 市、珠海市、江西省的南昌市、四川省的成都市、绵阳、湖南省的长沙、陕西省的西安市、杨凌、甘肃省的兰州、宁夏的银川、新疆的乌鲁木齐、广西省的南 宁市、山东省的济南、青岛、东北三省辽宁省的沈阳市、大连市、吉林省的长春市、黑龙江省的哈尔滨市等中国绝大部分省市和自治区。

上海华雅思创拥有zui大的干细胞B2B资源【干细胞搜网】www.stemcell.so，为电子商务的*，华雅思创代理生物领域的各种品牌产品多达300余品牌，累计产品超过17000多样，选择好的生物干细胞实验耗材，生物试剂类产品，生物仪器类产品，同时【干细胞搜网】也是zui大的干细胞资讯站，包括干细胞治疗，干细胞技术动态，干细胞zui前沿的资讯，更多【干细胞资讯尽在---干细胞搜网】